氢吗啡酮联合罗哌卡因用于妇科术后自控硬膜外镇痛
[Abstract]:Objective to investigate the feasibility and adverse effects of hydromorphine combined with ropivacaine for patient-controlled epidural analgesia (PCEA) after gynecological surgery. Methods 120 gynecological patients undergoing epidural anesthesia and requiring postoperative analgesia were randomly divided into three groups (40 cases in each group). All three groups were treated with PCEA at the end of operation. 4 渭 g / ml ropivacaine 1 渭 g / mL ropivacaine, 4 渭 g / ml ropivacaine, 4 渭 g / mL ropivacaine, 40 渭 g / m ~ (-1) ropivacaine 1 mg / m ~ (-1) in HR group. To evaluate the static and dynamic pain visual analogue scale scores (VAS) and Ramsay sedation score) at 2 h (T 1) 4 h (T 2) 8 h (T 3) 12 h (T 4) 24 h (T 5) and 36 h (T 6) and 48 h (T 7) after operation, and to record the times of self-controlled compression and the occurrence of adverse reactions. Results there was no significant difference in static pain VAS between HR group and Mr group (P0.05), and there was no significant difference in dynamic VAS and Ramsay sedation score between three groups at different time points after T1~T4 (P 0.05), but there was no significant difference in static pain VAS between HR group and Mr group at different time points after T1~T4 (P0.05), and there was no significant difference in dynamic VAS and Ramsay sedation score between HR group and Mr group (P0.05). The times of self-controlled compression in H group were more than those in HR group and Mr group (P0.05), but there was no significant difference between the latter two groups (P0.05). The incidence of nausea and vomiting was higher than that of the other two groups, and the first time of anal exhaust was prolonged after operation (P0.05). There was no significant difference between H group and HR group (P0.05). Conclusion Hydromorphone combined with ropivacaine can obtain more satisfactory analgesic effect and less adverse reaction after gynecological operation with ropivacaine.
【作者单位】: 武汉大学人民医院麻醉科;
【分类号】:R614
【共引文献】
相关期刊论文 前5条
1 金元;彭宇;林海;皮治兵;;奥施康定与芬太尼透皮贴治疗中重度癌症痛的疗效比较[J];中国地方病防治杂志;2014年S1期
2 刘小立;;氢吗啡酮微创全身给药治疗难治性癌痛[J];中国新药杂志;2014年14期
3 简文亭;简道林;马会改;;氢吗啡酮的临床应用[J];医药导报;2014年09期
4 熊雄;熊双宝;周德祥;;盐酸氢吗啡酮伍用酮咯酸氨丁三醇在老年患者术后经静脉患者自控镇痛中的应用[J];中国医院用药评价与分析;2015年02期
5 王华;邵东华;马鹏;;天麻素对癌痛模型小鼠热痛觉过敏阈值的影响[J];江苏大学学报(医学版);2015年03期
【相似文献】
相关期刊论文 前10条
1 刘汝;胡啸玲;易汉;冯娟;文建;;盐酸氢吗啡酮的临床研究进展[J];中国处方药;2014年03期
2 陈华;毛睿;南楠;;盐酸氢吗啡酮双层渗透泵片的体外释放度考察[J];药物分析杂志;2009年12期
3 陈磊;尹萍;邱毅;宁亚清;崔艳英;潘励山;;盐酸氢吗啡酮身体依赖性潜力[J];中国药物依赖性杂志;2008年05期
4 李小燕,陈笑艳,严青英,张志宏,徐静华,金鑫,钟大放;液相色谱-串联质谱法测定比格犬血浆中氢吗啡酮[J];药学学报;2004年11期
5 罗雪梅;丁黎;潘寅兵;孙鲁宁;饶雅琨;何明枫;王美青;刘存明;钱燕宁;;人血浆中氢吗啡酮的LC-MS测定方法及其应用[J];药学与临床研究;2012年04期
6 刘小立;;氢吗啡酮微创全身给药治疗难治性癌痛[J];中国新药杂志;2014年14期
7 程樱;张春瑛;乐晓红;;盐酸氢吗啡酮注射液无菌检查的方法验证[J];中国药师;2006年07期
8 杨秀林;徐振宇;孔祥飞;徐肇鸣;王文丽;;盐酸氢吗啡酮用于麻醉复苏及术后PCIA镇痛的临床研究[J];黔南民族医专学报;2014年02期
9 孔令峰;纳洛酮在危重急症中的应用[J];中国临床药学杂志;1996年04期
10 ;利用细菌制造止痛药新方法[J];化工文摘;2001年05期
相关会议论文 前2条
1 莫世湟;;盐酸氢吗啡酮在麻醉之临床应用[A];2010中华医学会全国麻醉学术年会论文汇编[C];2010年
2 李小燕;陈笑艳;徐静华;金鑫;钟大放;;LC-MS/MS法测定比格犬血浆中氢吗啡酮[A];中国有机质谱学第十二届全国学术大会论文集[C];2003年
相关重要报纸文章 前2条
1 黄敏燕邋译;渗透控释口服氢吗啡酮有效治疗慢性腰背疼痛[N];中国医药报;2008年
2 盛延东 编译;美Purdue Pharma公司将被停销盐酸氢吗啡酮[N];中国医药报;2005年
,本文编号:2165515
本文链接:https://www.wllwen.com/yixuelunwen/mazuiyixuelunwen/2165515.html